Gain Therapeutics, Inc. (GANX) ownership: Top institutional holder: MARSHALL WACE, LLP ($3.43M). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| MARSHALL WACE, LLP | 1769788.00 | $3.43M | 2026-03-31 |
| Potomac Capital Management, Inc. | 1008600.00 | $1.96M | 2026-03-31 |
| GREENLIGHT CAPITAL INC | 588410.00 | $1.92M | 2023-12-31 |
| VANGUARD GROUP INC | 569901.00 | $1.84M | 2025-12-31 |
| JONES FINANCIAL COMPANIES LLLP | 631615.00 | $1.16M | 2026-03-31 |
| Cambridge Investment Research Advisors, Inc. | 568645.00 | $1.10M | 2026-03-31 |
| DME Capital Management, LP | 566130.00 | $1.10M | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 447342.00 | $868527.00 | 2026-03-31 |
Back to GANX overview · GANX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.